100 QUESTIONS IN CARDIOLOGY

(Michael S) #1

40 How soon before cardiac surgery should


aspirin be stopped?


Jonathan Unsworth-White


Aspirin irreversibly inhibits platelet function by blocking the

cyclooxygenase pathway. It is a vital adjunct in the prevention of

coronary thrombosis^1 and is known to reduce the risk of acute

bypass graft closure.^2 Unfortunately it also causes increased

bleeding after cardiac surgery and increases the risk of emergency

re-sternotomy in the first few hours.^3 For this reason many centres

try to stop aspirin for a few days prior to surgery.

Platelets have a life span in the plasma of approximately 10 days.

Therefore if aspirin were discontinued 10 days prior to surgery, the

affected platelet pool would be completely replenished with fresh

platelets by the time of the operation. This however leaves the

patient vulnerable to an acute myocardial event during the latter

part of this time and may also make graft occlusion more likely in

the immediate postoperative period. It also supposes that

operating lists can be planned 10 days in advance.

In reality, patients are usually asked to stop aspirin 5–7 days in

advance. This seems to be a suitable compromise for the majority

of patients although for a few (tight left main stem stenosis or past

history of TIAs or stroke), the risk of stopping aspirin may

outweigh the potential benefits.

RReeffeerreenncceess
1 Antiplatelet Trialists’ Collaboration. Collaborative overview of
randomised trials of antiplatelet therapy-1: Prevention of death,
myocardial infarction, and stroke by prolonged antiplatelet therapy in
various categories of patients.BMJ1994; 330088 : 81–106.
2 Antiplatelet Trialists’ Collaboration. Collaborative overview of
randomised trials of antiplatelet therapy-II: Maintenance of vascular
graft or arterial patency by antiplatelet therapy.BMJ1994; 330088 : 159–68.
3 Kallis P, Tooze JA, Talbot S,et al. Pre-operative aspirin decreases
platelet aggregation and increases post-operative blood loss – a
prospective, randomised, placebo controlled, double-blind clinical
trial in 100 patients with chronic stable angina.Eur J Cardio-thorac Surg
1994; 88 : 404–9.

Free download pdf